Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ)

9.14 +0.28 (+3.16%) At close: 03:04PM CST

Harbin Medisan Pharmaceutical Co., Ltd.

Beijing Road
Limin Development Zone
Harbin 150025
China
86 45 1573 55689
https://www.medisan.com.cn

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2,115

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jian Fei Qin	Chairman & President	N/A	N/A	1963
Mr. Zhicheng Zhao	Financial Director	N/A	N/A	1975
Mr. Yan Fei Liang	VP, Board Secretary & Director	N/A	N/A	1967

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical product and medical devices in China. The company offers various drugs for nervous system, cardiovascular system, musculoskeletal system, systemic anti-infective, basic infusions, nutritional infusion, anti-tumor and immunomodulators, digestive tract, metabolism, etc. It also produces and sells cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.

Corporate governance

Harbin Medisan Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.